Fengmin Zhao

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Ejection Fraction

Top Venues

Cancer medicine

Dana Farber Cancer Institute

Johns Hopkins University Bloomberg School of Public Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute

United States

Biostatistician :: Biostatistics and computational biology

Education History

Johns Hopkins University Bloomberg School of Public Health

United States

PHD :: Population, family and reproductive health

Chinese Center for Disease Control and Prevention

China

MSC :: Epidemiology

Publications

Edward Haksing Ip, Santiago Saldana, Kathy D Miller, Ruth C Carlos, Ilana F Gareen, Joseph A Sparano, Noah Graham, Fengmin Zhao, Ju-Whei Lee, Nathaniel S O'Connell, David Cella, John Devin Peipert, Robert J Gray, Lynne I Wagner
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events. Cancer 127 (24) (2021)
Samilia Obeng-Gyasi, Anne O'Neill, Fengmin Zhao, Sheetal M Kircher, Timisina R Lava, Lynne I Wagner, Kathy D Miller, Joseph DA Sparano, George W Sledge, Ruth C Carlos
Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer. Cancer medicine 10 (1) (2020)
Christine S Ritchie, Fengmin Zhao, Kanan Patel, Judith Manola, Elizabeth A Kvale, Claire F Snyder, Michael J Fisch
Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors. Cancer 123 (19) (2017)